Fresh analysis indicates that people who stop using popular slimming jabs like semaglutide or tirzepatide may regain shed pounds far faster than those who end traditional diet and exercise programs.
Published data in a prominent health publication demonstrates that while overweight individuals often shed a large proportion of their total mass while on the medication, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"Users purchasing such medications should be aware of the potential of fast weight regain when the therapy is stopped," stated expert Dr. Susan Jebb.
This pace of recovery implies a return to starting weight within about one and a half years.
Analyzing Approaches
The study, which reviewed 37 of trials involving thousands of participants, contrasted the outcomes of these new drugs with other pills.
Scientists note that people who shed pounds through dieting usually have a less rapid weight regain—around 100 grams monthly—post-intervention.
Explaining the Fast Rebound
Doctors believe the mechanism of the drugs explains the accelerated weight return.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Long-term administration of GLP-1 concentrations far above than normal might result in the body to generate a reduced amount of its endogenous GLP-1, and could reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.
"Withdrawal of this hormone supplement means hunger is unsuppressed, making overeating a significant risk."
An Ongoing Disease?
Health authorities advise the injections for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians argue that, due to the significant potential of weight regain, the treatment is often ongoing.
This perspective is reinforced by pharmaceutical companies, who note that the findings "emphasize the persistent character of excess weight," similar to managing conditions like high blood pressure.
Patient Experiences
Users who have come off the jabs explain a powerful resurgence of hunger.
"It felt as if a trigger that goes on and I was suddenly ravenous," recalled one woman.
This difficulty is worsened if users have not adopted lasting dietary or behavioural modifications during therapy.
Significant Interest
Recent estimates suggest that a significant number of people in the UK have tried these injections in the past year, with demand being substantial.
- Use is more common among females compared to men.
- The middle-aged demographic shows the highest usage rates.
- A large proportion obtain the medications through private healthcare rather than the NHS.
Ultimately, clinicians caution that while these medications are powerful agents for weight loss, they are not a magic cure and long-term success relies on ongoing behavioural changes.
